Eagle LogoPEPTIDE INITIATIVE

Peptide Database

Goals
Fat LossMuscle BuildingInjury HealingAnti-AgingCognitive EnhancementSleep OptimizationImmune SupportGut HealingSkin RejuvenationSexual Health
Peptides
5-Amino-1MQ
Weight Management
Abarelix
Hormone Support
Acetyl Hexapeptide-3 (Argireline)
Cosmetic
Adipotide
Weight Management
Adrenomedullin
Healing & Recovery
Alexamorelin
Growth Hormone
Angiotensin (1-7)
Healing & Recovery
AOD-9604
Weight Management
Apelin-13
Healing & Recovery
ARA-290 (Cibinetide)
Healing & Recovery
Bestatin (Ubenimex)
Immune
BPC-157
Healing & Recovery
Buserelin
Hormone Support
Cagrilintide
Weight Management
CagriSema
Weight Management
Capromorelin
Growth Hormone
Cartalax
Anti-Aging
Cathelicidin (hCAP-18 / Synthetic Derivatives)
Immune
Cerebrolysin
Cognitive
Cerluten
Cognitive
Cetrorelix
Hormone Support
Chonluten
Immune
CJC-1295 (No DAC)
Growth Hormone
CJC-1295 with DAC
Growth Hormone
Cortexin
Cognitive
Crystagen
Immune
Daptomycin
Immune
Defensin (HBD-2)
Immune
Defensin (HBD-3)
Immune
Degarelix
Hormone Support
Dihexa
Cognitive
DSIP (Delta Sleep-Inducing Peptide)
Sleep & Recovery
Dulaglutide
Weight Management
Enalapril
Healing & Recovery
Epithalon
Anti-Aging
Exenatide
Weight Management
Fertirelin
Hormone Support
FOXO4-DRI
Anti-Aging
Ganirelix
Hormone Support
GHK-Cu (Copper Peptide)
Cosmetic
GHRH (1-29)
Growth Hormone
GHRP-2
Growth Hormone
GHRP-6 (Growth Hormone Releasing Peptide-6)
Growth Hormone
Glutathione
Anti-Aging
Gonadorelin (GnRH)
Hormone Support
Gramicidin
Immune
Hexarelin
Growth Hormone
Human Chorionic Gonadotropin (HCG)
Hormone Support
Human Growth Hormone (HGH)
Growth Hormone
IGF-1 LR3
Growth Hormone
Immunoxel (Dzherelo)
Immune
Imunofan
Immune
Intermedin (Adrenomedullin-2)
Healing & Recovery
Ipamorelin
Growth Hormone
Kisspeptin-10
Sexual Health
KPV (Alpha-MSH Fragment)
Healing & Recovery
Lactoferricin B
Immune
Larazotide
Healing & Recovery
Lentinan
Immune
Leuphasyl
Cosmetic
Leuprolide
Hormone Support
Liraglutide
Weight Management
Livagen
Anti-Aging
Lixisenatide
Weight Management
LL-37
Immune
Macimorelin
Growth Hormone
Magainin-2
Immune
Mazdutide
Weight Management
Melanotan-2
Cosmetic
MK-677 (Ibutamoren)
Growth Hormone
MOTS-c
Metabolic
Myristoyl Pentapeptide-17
Cosmetic
N-Acetyl Selank
Cognitive
N-Acetyl Semax Amidate
Cognitive
NAD+
Mitochondrial
Nafarelin
Hormone Support
Natriuretic Peptide (ANP)
Healing & Recovery
Nesiritide (BNP)
Healing & Recovery
Nisin
Immune
Noopept (Omberacetam)
Cognitive
Orforglipron
Weight Management
Ovagen
Anti-Aging
Oxytocin Acetate
Hormone Support
P21 (P021)
Cognitive
PACAP-38
Healing & Recovery
Palmitoyl Oligopeptide
Cosmetic
Palmitoyl Pentapeptide-4 (Matrixyl)
Cosmetic
Palmitoyl Tetrapeptide-7
Cosmetic
Palmitoyl Tripeptide-1
Cosmetic
Pancragen
Metabolic
PEG-MGF
Healing & Recovery
Pemvidutide
Weight Management
Pentadecapeptide (BPC Analog)
Healing & Recovery
Pidotimod
Immune
Pinealon
Cognitive
PNC-27
Immune
Polymyxin B
Immune
Pralmorelin (GHRP-2)
Growth Hormone
Pramlintide
Weight Management
Prostamax
Hormone Support
PT-141 (Bremelanotide)
Sexual Health
Relaxin-2 (Serelaxin)
Healing & Recovery
Retatrutide
Weight Management
Selank
Cognitive
Semaglutide
Weight Management
Semax
Cognitive
Sermorelin
Growth Hormone
Setmelanotide
Weight Management
SLU-PP-332
Metabolic
SM-130686
Growth Hormone
Snap-8
Cosmetic
SS-31 (Elamipretide)
Mitochondrial
Substance P Antagonists
Healing & Recovery
Survodutide
Weight Management
SYN-AKE
Cosmetic
Tabimorelin
Growth Hormone
TB-500
Healing & Recovery
Tesamorelin
Growth Hormone
Testagen
Hormone Support
Thymalin
Immune
Thymopentin (TP-5)
Immune
Thymopoietin
Immune
Thymosin Alpha-1
Immune
Thymosin Beta-4
Healing & Recovery
Thymulin (FTS)
Immune
Thymulin Analog (PAT)
Healing & Recovery
Tirzepatide
Weight Management
Tripeptide-29
Cosmetic
Triptorelin
Hormone Support
Ularitide
Healing & Recovery
Urocortin
Healing & Recovery
Ventfort
Anti-Aging
Vesilute
Hormone Support
Vilon
Immune
VIP (Vasoactive Intestinal Peptide)
Healing & Recovery
Xenin-25
Metabolic
Ziconotide (Prialt)
Healing & Recovery
Total Peptides: 137
Back to Home
Back to Triptorelin

Clinical trials

Every registered trial of Triptorelin

311 studies, 43 still enrolling.

Plain-Language Summary

Plain-language reading of the public trial registries.

In short

  • Triptorelin has been studied in people a great deal.
  • 311 registered studies in total.
  • 43 are still enrolling people, so this is active research, not just history.

What kind of research

  • 285 studies actually gave the peptide to volunteers and measured what happened. This is the kind of study that can show whether something works.
  • About 73,119 people took part in those.
  • A further 26 studies only looked at records of people already taking it. These are counted separately because nobody was given the peptide for the study, so they cannot prove cause and effect.

How far along it is

  • 134 trials have reached phase 3 or 4 — the large, late-stage trials regulators rely on to approve a drug.
  • 67 have published results in the medical literature that anyone can read.
  • The research spans 61 countries.

A registered trial is a plan, not a result. Registration means a study was declared in advance; it says nothing about whether the peptide worked, and a trial can be registered and then abandoned.

Filter

Showing 311 of 311 trials for Triptorelin.

  • NCT07782840Phase 2Not Yet Recruiting40 enrolled2026

    QL1706 Plus Neoadjuvant Endocrine Therapy in HR-Positive/HER2-Negative Breast Cancer With a Poor Response to Neoadjuvant Chemotherapy

    Hebei Medical University Fourth Hospital

    Breast Cancer

  • NCT07751133Phase 3Not Yet Recruiting1,500 enrolled2026

    Evaluating Hormone Therapy to Achieve Optimal Doses in Metastatic Prostate Cancer

    University College, London

    Prostate Cancer · mHSPC · mCRPC

  • NCT07455903Phase 2Recruiting50 enrolled2026

    Assessing Efficacy of Neoadjuvant ADT in Localized High-Risk Prostate Cancer Patients Utilizing 18F-Flotufolastat PSMA PET/CT

    Baptist Health South Florida

    Prostate Cancer · Localized Prostate Carcinoma

  • 2026-526292-37-01Ongoing126 enrolled2026

    Triggerbest

    Instituto De Investigacion Sanitaria Fundacion Para La Investigacion Del Hospital Clinico De Valencia-INCLIVA

    Women with infertility and low ovarian reserve.

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT06913075Not Yet Recruiting700 enrolled2026

    FET in Adenomyosis

    Indira IVF Hospital Pvt Ltd

    Adenomyosis

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT06763926Phase 4Not Yet Recruiting154 enrolled2026

    Intranasal Nafarelin For Triggering Oocyte Maturation

    Fundacion Dexeus

    Fertility Preservation

  • NCT07569315Phase 2Not Yet Recruiting190 enrolled2026

    Successive Doses of GnRH Agonist Versus Single Dose of GnRH Agonist to Trigger Ovulation in Hyper-responders

    Bedaya Hospital

    Infertility

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT07569289Phase 2Not Yet Recruiting164 enrolled2026

    Triggering Oocyte Maturation in POSEIDON Group 3 and 4 Poor Responders Using Double Trigger or HCG Trigger

    Bedaya Hospital

    Infertility

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT07569302Phase 2Not Yet Recruiting196 enrolled2026

    Triggering Ovulation in Normo-responders Using a Modified Dual Trigger Protocol or HCG Trigger

    Bedaya Hospital

    Infertility (IVF Patients)

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT07477626Phase 3Recruiting372 enrolled2026

    Radiotherapy After Prostatectomy for Node Positive Prostate Cancer

    Sun Yat-sen University

    Prostate Cancer (Post Prostatectomy) · Radiotherapy; Image-Guided · Prostate Cancer Non-Metastatic · Androgen Deprivation Therapy

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT07142551Phase 2Recruiting60 enrolled2026

    Supraphysiologic Testosterone Priming Induces Darolutamide Extended Response

    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

    Metastatic Castration-resistant Prostate Cancer

  • NCT07319429Phase 2/3Recruiting260 enrolled2026

    Refining Fertility-sparing Treatment in Endometrial Carcinoma Based on Molecular Classification

    Fudan University

    Endometrial Cancer · Fertility

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • 2025-522525-34-00Ongoing62 enrolled2026

    Effect of Semaglutide on embryo quality in overweight and obese patients undergoing In Vitro Fertilization. A Randomized Controlled Trial

    Santiago Dexeus Font Fundacio Privada

    Infertility

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT07268794Phase 2Not Yet Recruiting112 enrolled2025

    CONVERT-HB1: Radical Prostatectomy After Systemic Therapy for High-volume Metastatic Hormone-sensitive Prostate Cancer

    Fudan University

    Metastatic Prostate Cancer · Prostate Cancer (Adenocarcinoma) · Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT07254429Phase 2Recruiting192 enrolled2025

    COMPASS - COpenhagen MenoPAuSe Study

    Martin Blomberg Jensen

    Menopausal Osteoporosis · Bone Markers

  • NCT06922318Phase 2Recruiting50 enrolled2025

    The COSMYC Trial (COmbined Suppression of MYC)

    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

    Metastatic Castration-resistant Prostate Cancer

  • NCT07696351Phase 4Recruiting120 enrolled2025

    Ultra-Long GnRH-a Pretreatment for FET Outcomes in Patients With Deep Infiltrating Endometriosis

    Li-jun Ding

    Deep Infiltrating Endometriosis (DIE) · Infertility

  • NCT06732843Recruiting10 enrolled2025

    Does Recombinant FSH (rFSH, i.g. Gonal F®) as Compared to Human Menopausal Gonadotrophin (hMG) Affect Telomere Length of Cumulus Cells During Antral Follicle Growth and Impact Blastocyst Status?

    ART Fertility Clinics LLC

    OVARIAN STIMULATION · Telomere Length · Telomere Length, Mean Leukocyte

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT06795178Phase 3Withdrawn2025

    Efficacy, Safety, and Pharmacokinetics of FP-014, 11.25 mg in Patients With Advanced Prostate Cancer

    Foresee Pharmaceuticals Co., Ltd.

    Prostate Cancer

  • NCT06795191Phase 3Withdrawn2025

    Efficacy, Safety, and Pharmacokinetics of FP-014, 22.5 mg in Patients With Advanced Prostate Cancer

    Foresee Pharmaceuticals Co., Ltd.

    Prostate Cancer

  • NCT06528210Phase 2Withdrawn2025

    Pembrolizumab With Androgen Deprivation Therapy and Radiotherapy for the Treatment of Patients With High Risk Localized Prostate Cancer

    OHSU Knight Cancer Institute

    High Risk Prostate Carcinoma · Localized Prostate Adenocarcinoma · Stage I Prostate Cancer AJCC v8 · Stage II Prostate Cancer AJCC v8

  • NCT06513962Phase 3Recruiting60 enrolled2025

    Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer

    Children's Oncology Group

    Hematopoietic and Lymphatic System Neoplasm · Malignant Solid Neoplasm

  • 2023-509787-15-00Ongoing600 enrolled2025

    UC-GTG-2310

    Unicancer

    Patients with localised prostate cancer and high-risk features of relapse (minimum 2 high-risk criteria from National Comprehensive Cancer Network (NCCN) classification)1 and with no detectable metastasis, including no evidence of pelvic lymph node metastasis on next-generation imaging (PSMA PET/CT).

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT06734130Phase 2Active Not Recruiting25 enrolled2025

    Adaptive Androgen Deprivation and Docetaxel in Metastatic Castration Sensitive Prostate Cancer

    H. Lee Moffitt Cancer Center and Research Institute

    Metastatic Castration Sensitive Prostate Cancer

  • NCT06572930Recruiting150 enrolled2024

    Serum FSH Monitoring for Identification of an Optimal Range During Ovarian Stimulation

    ART Fertility Clinics LLC

    Ovarian Stimulation

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT06739759Recruiting300 enrolled2024

    Ovarian Hyperstimulation Syndrome Prevention

    Aljazeera Hospital

    Ovarian Hyper Stimulation Syndrome (OHSS)

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • 2024-519126-20-00Revoked180 enrolled2024

    2019_0012

    Hospital Foch

    Endometriosis, adenomyosis

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • 2024-514322-23-00Revoked110 enrolled2024

    FSD-IEQ-2021-03

    Santiago Dexeus Font Fundacio Privada

    infertility

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT06396390Phase 4Unknown152 enrolled2024

    Comparison of Progestin Primed Ovarian Stimulation (PPOS) vs.GnRH Antagonist Methods on IVF Outcomes

    Nesta Clinic

    IVF · Fertility Issues · Infertility

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT06487143Phase 4Not Yet Recruiting134 enrolled2024

    Efficacy, Metabolism and BMD of the 3-month TP Compared to the 1-month TP in ICPP

    Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

    Central Precocious Puberty

  • NCT06150703Phase 3Recruiting652 enrolled2024

    Luteal Phase Support With GnRH Agonist After GnRH Agonist Triggering in IVF/ICSI Cycles

    Assistance Publique - Hôpitaux de Paris

    In Vitro Fertilization · ICSI Intracytoplasmic Spermatozoid Injection

  • 2023-505126-34-00Temporarily Halted652 enrolled2024

    APHP220667

    Assistance Publique Hopitaux De Paris

    IVF (In vitro fertilization) or ICSI (intracytoplasmic sperm injection) protocol with embryo transfer planned on the same cycle.

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • 2024-512023-37-00Temporarily Halted202 enrolled2024

    CTOR18001GZA

    Ziekenhuis Aan De Stroom

    Prostate cancer

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT06378866Phase 2Recruiting532 enrolled2024

    Stereotactic Body Radiation Therapy Plus Immediate or Delayed Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy or Salvage Radiation Therapy for the Treatment of Prostate Cancer, DIVINE Trial

    Mayo Clinic

    Recurrent Castration-Sensitive Prostate Carcinoma · Recurrent Prostate Cancer · Castration-resistant Prostate Cancer · Biochemically Recurrent Prostate Carcinoma

  • NCT06481696Unknown90 enrolled2024

    Possible Action of Resveratrol in Improving the Outcomes of IVF/ICSI in Couples With Unexplained Infertility

    Andros Day Surgery Clinic

    Unexplained Infertility

  • NCT07128394Recruiting590 enrolled2024

    Extra Luteinizing Hormone Improve Embryo Quality in IVF Patients With Low LH During Long GnRH-Agonist Treatment

    Nanjing University

    Infertility, Female · Luteinizing Hormone (LH)

  • 2022-503013-32-00Revoked175 enrolled2024

    67-22 PREcoopERA

    ETOP IBCSG Partners Foundation

    ER-positive/HER2-negative early breast cancer

  • NCT05896566Phase 2Completed231 enrolled2024

    A Window-of-Opportunity Trial of Giredestrant +/- Triptorelin vs. Anastrozole + Triptorelin in Premenopausal Patients With ER-positive/HER2-negative Early Breast Cancer

    ETOP IBCSG Partners Foundation

    Breast Cancer

  • NCT06525155Phase 3Recruiting32 enrolled2024

    Effect GnRH Agonist Administration in Endometriosis Cyst Patients

    Rumah Sakit Pusat Angkatan Darat Gatot Soebroto

    Endometriosis

  • NCT06146413Phase 2Unknown150 enrolled2023

    Triggering Oocyte Maturation in Normoresponders Using Double Trigger or HCG Trigger

    Bedaya Hospital

    Infertility

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT06134479Phase 3Completed194 enrolled2023

    Comparison of Sequential CFA vs CFA +rFSH for Elective Fertility Preservation.

    Fundación Santiago Dexeus Font

    Fertility

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT06581679Completed184 enrolled2023

    Adenomyosis and Pregnancy: Levonorgestrel vs. GnRH for Blastocyst Transfer

    Zagazig University

    Adenomyosis

  • NCT06282588Phase 2/3Recruiting493 enrolled2023

    Treatment of High-Risk Prostate Cancer Guided by Novel Diagnostic Radio- and Molecular Tracers

    Cancer Research Antwerp

    Prostate Cancer

  • 2022-501551-90-00Ongoing493 enrolled2023

    CTO21042GZA

    Ziekenhuis Aan De Stroom

    Prostate cancer

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • 2023-507028-22-00Ongoing110 enrolled2023

    FSD-INO-2023-14

    Santiago Dexeus Font Fundacio Privada

    Infertility

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • 2023-506162-31-00Revoked194 enrolled2023

    FSD-SEQ-2023-09

    Santiago Dexeus Font Fundacio Privada

    Infertility

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT05851547Phase 2Recruiting54 enrolled2023

    Dose Escalation For INtraprostatic LEsions

    Ottawa Hospital Research Institute

    Prostatic Neoplasms

  • 2023-504188-18-00Ongoing150 enrolled2023

    IBMR43

    Instituto Bernabeu S.L.

    Women undergoing ovarian stimulation for oocyte donation.

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT05879926Phase 3Recruiting3,960 enrolled2023

    Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

    NRG Oncology

    Breast Cancer

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT06059118Phase 2Recruiting50 enrolled2023

    Difluoromethylornithine and High Dose Testosterone With Enzalutamide in Metastatic Castration-Resistant Prostate Cancer

    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

    Prostate Cancer

  • NCT03717870Not Yet Recruiting100 enrolled2023

    Surgery and ART For Endometrioma

    Università degli Studi dell'Insubria

    Ovarian Endometrioma · Infertility, Female

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT07076719Completed20 enrolled2023

    Cell-free DNA Analysis of Spent Embryo Culture Media as a Non-invasive Approach for Preimplantation Genetic Diagnosis

    Sohag University

    to Evaluate the Feasibility and Accuracy of Using cfDNA Analysis of Spent Embryo Culture Media as a Non-invasive Approach for PGD

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • 2023-503373-37-01Ongoing96 enrolled2023

    SOLTI-2104

    Solti Group

    Premenopausal women with early luminal breast cancer

  • NCT05802303Terminated172 enrolled2023

    Estrogen (Gel)Transdermal vs Oral Estrogen for Endometrial Preparation

    Indira IVF Hospital Pvt Ltd

    Frozen Embryo Transfer · Infertility, Female

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT05972902Phase 3Unknown387 enrolled2023

    Dydrogesterone, Cetrorelix Acetate and Triptorelin in Intra Cytoplasmic Sperm Injection Outcomes

    Beni-Suef University

    IVF

  • NCT04157725Phase 4Unknown154 enrolled2023

    Mild Stimulation Protocol Using Clomiphene Citrate for Women With PCOS Undergoing in Vitro Fertilization

    American University of Beirut Medical Center

    PCO - Polycystic Ovaries · Infertility

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT05759273Completed167 enrolled2023

    A Study to Observe Demography and the Outcome of Prostate Cancer Patients Treated With 6-month Triptorelin Formulation in Italy

    Ipsen

    Prostate Cancer

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT05328258Phase 3Recruiting500 enrolled2023

    Use of GnRHa During Chemotherapy for Fertility Protection

    Kenny Rodriguez-Wallberg

    Breast Cancer Female · Acute Leukemia · Lymphoma · Osteosarcoma

  • NCT05746806Active Not Recruiting36 enrolled2023

    Trial of Ultrahypofractionated Focal Salvage Radiotherapy for Isolated Prostate Bed Recurrence After Radical Prostatectomy

    Insel Gruppe AG, University Hospital Bern

    Recurrent Prostate Cancer

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT05781217Phase 3Recruiting534 enrolled2023

    Short Versus Long-term Androgen Deprivation Therapy With Salvage Radiotherapy in Prostate Cancer. URONCOR 0624

    Instituto de Investigación en Oncología Radioterápica - Fundación Española de Oncología Radioterápic

    Prostate Cancer · Salvage Radiotherapy · Biochemical Recurrence · Androgen Deprivation Therapy

  • 2024-517666-41-00Ongoing534 enrolled2023

    URONCOR 06-24

    Instituto De Investigacion En Oncología Radioterapica FEOR

    Prostate Cancer

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT05555017Phase 2Unknown60 enrolled2023

    Tracer-Guided Surgery for Recurrent Prostate Cancer

    The Netherlands Cancer Institute

    Prostate Cancer

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT06191809Unknown200 enrolled2023

    Evaluate the Effectiveness of Progestin-Primed Versus GnRH Antagonist Protocols in Vietnamese Women Undergoing In-vitro Fertilization

    Hanoi Medical University

    IVF

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT05701007Completed1,083 enrolled2023

    Real World Evidence Study on Metastatic Prostate Cancer in the Pirkanmaa Hospital District in Finland

    Pfizer

    Metastatic Castration Sensitive Prostate Cancer (mCSPC) · Metastatic Castration Resistant Prostate Cancer (mCRPC)

  • NCT05982093Phase 2Recruiting96 enrolled2023

    Elacestrant With/Without Triptorelin in Premenopausal Women With Luminal Breast Cancer

    SOLTI Breast Cancer Research Group

    Breast Cancer · HER2-negative Breast Cancer · Hormone Receptor Positive Tumor · Premenopausal Breast Cancer

  • NCT05498272Phase 2Active Not Recruiting32 enrolled2023

    Study of Neoadjuvant PARP Inhibition Followed by Radical Prostatectomy in Patients With Unfavorable Intermediate-Risk or High-Risk Prostate Cancer With Select HRR Gene Alterations

    Rana McKay, MD

    Prostate Cancer · BRCA1 Mutation · BRCA2 Mutation · Prostatic Adenocarcinoma

  • NCT05590793Phase 3Completed195 enrolled2022

    Effects of Triptorelin Pamoate 6-month When Given to Adult Chinese Participants With Advanced Cancer in the Prostate

    Ipsen

    Advanced Prostate Cancer · Metastatic Prostate Cancer · Locally Advanced Prostate Cancer

  • NCT04616729Phase 1/2Unknown30 enrolled2022

    DEPO-Trigger Trial: GnRH Agonist DEPOt TRIGGER for Final Oocyte Maturation

    Universitair Ziekenhuis Brussel

    Breast Cancer Female

  • NCT04586686Unknown41 enrolled2022

    Combining Interventions of Fertility Preservation to Mitigate Fertility Loss After Breast Cancer

    Universitair Ziekenhuis Brussel

    Breast Cancer Female

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT05567731Completed30 enrolled2022

    Effect of GnRH Agonist Treatment Protocols on Ovarian Reserve

    Tanta University

    Intracytoplasmic Sperm Injection · GnRH Agonist · Infertility · Ovarian Reserve

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT05838105Unknown144 enrolled2022

    Two Different Types of Luteal Phase Support in Natural Cycle Frozen Embryo Transfer and Its Effect on Pregnancy Rates

    Shaare Zedek Medical Center

    Luteal Phase Support

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT05458856Phase 3Completed147 enrolled2022

    Effects of Triptorelin When Given Every 6-months Under the Skin to Adult Males With Cancer in the Prostate

    Ipsen

    Prostate Cancer

  • NCT06691815Enrolling By Invitation48 enrolled2022

    Triptorelin for Early Diagnosis of Hypogonadotrophic Hypogonadism

    Hospital de Niños R. Gutierrez de Buenos Aires

    Pubertal Delay · Hypogonadism, Hypogonadotropic · Constitutional Delay in Growth and Puberty (CDGP)

  • NCT05397795Phase 3Unknown160 enrolled2022

    COMPARING TWO PROTOCOLS FOR FINAL OOCYTE MATURATION IN POOR RESPONDERS UNDERGOING GnRH-ANTAGONIST ICSI CYCLES

    Alexandria University

    Infertility

  • NCT03940807Phase 3Withdrawn2022

    Impact of Ultra-long Versus Long Down-regulation Protocol on IVF/ICSI in Adenomyosis

    University Hospital, Toulouse

    Adenomyosis

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • 2022-502373-42-00Ongoing1,073 enrolled2022

    S65935

    UZ Leuven

    Oligorecurrent hormone-sensitive prostate cancer patients

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT05212857Phase 2Unknown160 enrolled2022

    Enhanced Systemic Combined With Local Treatment for Primary and Metastatic Lesions in Oligo-metastatic Prostate Cancer

    Fudan University

    Prostate Cancer

  • NCT05286554Phase 4Completed75 enrolled2022

    Addition of Gonadotropin Releasing Hormone Agonist to Luteal Phase Support

    Alexandria University

    Female Infertility

  • NCT05321511Phase 4Unknown165 enrolled2022

    Comparison of Triggers in Double Ovarian Stimulation (DuoStim).

    Instituto Bernabeu

    IVF · LOW OVARIAN RESPONSE

  • NCT05189457Phase 2Active Not Recruiting32 enrolled2022

    First Strike, Second Strike Therapies for High Risk Metastatic Castration Sensitive Prostate Cancer

    H. Lee Moffitt Cancer Center and Research Institute

    Prostate Cancer · Stage IV Prostate Cancer

  • NCT05149131Completed960 enrolled2022

    A Study Called AWARENESS Using Data From Men in Alberta to Observe Treatment Patterns for Metastatic Castration-sensitive Prostate Cancer

    Bayer

    Metastatic Castration-sensitive Prostate Cancer

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT05050084Phase 3Active Not Recruiting2,050 enrolled2021

    Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score, The Guidance Trial

    NRG Oncology

    Prostate Adenocarcinoma

  • NCT05151016Early Phase 1Unknown140 enrolled2021

    Long-term Use of Mifepristone in the Treatment of Adenomyosis

    Women's Hospital School Of Medicine Zhejiang University

    Adenomyosis · Mifepristone

  • NCT05112692Unknown200 enrolled2021

    Progestin-primed Ovarian Stimulation Protocol Versus GnRH Antagonist Protocol in Polycystic Ovary Syndrome Patients Undergoing IVF/ICSI Cycles

    Mansoura University

    PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries

  • NCT04931342Phase 2Active Not Recruiting176 enrolled2021

    A Study Evaluating the Efficacy and Safety of Biomarker-Driven Therapies in Patients With Persistent or Recurrent Rare Epithelial Ovarian Tumors

    Hoffmann-La Roche

    Ovarian Cancer

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT04992468Phase 4Completed136 enrolled2021

    Dual Trigger for Elective Fertility Preservation

    Fundación Santiago Dexeus Font

    Infertility

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT05019846Phase 3Recruiting310 enrolled2021

    SRT Versus SRT+ADT in Prostate Cancer

    Marco Lorenzo Bonu

    Prostate Cancer

  • NCT05029622Phase 3Completed66 enrolled2021

    A Study to Assess the Efficacy and Safety of the Triptorelin 6-month Formulation in Paediatric Participants With Central Precocious Puberty.

    Ipsen

    Central Precocious Puberty

  • NCT04787744Phase 2/3Recruiting464 enrolled2021

    Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer

    VA Office of Research and Development

    Prostate Cancer · Oligometastasis · Oligorecurrence · Recurrent Prostate Cancer

  • NCT05969834Completed100 enrolled2021

    HCG Levels After Ovulation Triggering as Predictors of ICSI Outcome

    Mansoura University

    Infertility

  • NCT04736602Phase 3Completed32 enrolled2021

    Efficacy and Safety Study of Triptorelin 3-Month Formulation in Chinese Children With Central Precocious Puberty.

    Ipsen

    Central Precocious Puberty

  • NCT04356664Phase 2/3Recruiting180 enrolled2021

    Benefit of GnRH Agonist Before Frozen Embryo Transfer in Patients With Endometriosis and/or Adenomyosis

    Hopital Foch

    Endometriosis · Adenomyosis · Infertility, Female

  • NCT04484818Phase 3Active Not Recruiting27 enrolled2021

    Testing the Addition of Darolutamide to Hormonal Therapy (Androgen Deprivation Therapy [ADT]) After Surgery for Men With High-Risk Prostate Cancer, The ERADICATE Study

    ECOG-ACRIN Cancer Research Group

    Prostate Carcinoma

  • NCT04749979Unknown100 enrolled2021

    Freeze All on Oocyte Maturatin by Gonadotropin Agonist Versus Human Chorionic Gonadotroipin

    Aljazeera Hospital

    Infertility

  • NCT05557604Phase 2Recruiting146 enrolled2021

    Sbrt±sTad for Unfavorable iNtermediate rIsk/High Risk Prostate caNcer

    Regina Elena Cancer Institute

    Prostate Cancer

  • NCT04753177Phase 2/3Unknown120 enrolled2021

    The Neoadjuvant Combined Hormone Therapy in Premenopausal Women With Locally Advanced ER+/HER2- Breast Cancer

    Saint Petersburg State Budgetary Healthcare Institution, City Clinical Oncology Dispensary

    The Neoadjuvant Therapy

  • NCT04513717Phase 3Active Not Recruiting2,753 enrolled2021

    Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT Trial

    NRG Oncology

    Prostate Adenocarcinoma · Stage III Prostate Cancer AJCC v8 · Stage IVA Prostate Cancer AJCC v8

  • NCT04717752Unknown310 enrolled2021

    A Randomized Controlled Study of Different Trigger Modes of Antagonist Regimen in Patients With Low Ovarian Reserve

    Nanjing University

    Poor Ovarian Response

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT04973969Unknown100 enrolled2021

    Follicular Challenge Test to Predict Response to GnRH Agonist Triggering

    Assaf-Harofeh Medical Center

    Infertility, Female

  • NCT04557059Phase 3Active Not Recruiting692 enrolled2020

    A Study of Adding Apalutamide to Radiotherapy and LHRH Agonist in High-Risk Patients With Hormone-Sensitive Prostate Cancer

    Janssen Pharmaceutica N.V., Belgium

    Prostatic Neoplasms

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT04454749Terminated3 enrolled2020

    Endometrial Compaction and Its Influence on Pregnancy Rate in Frozen Embryo Cycle Regimes

    ART Fertility Clinics LLC

    Endometrial Disorder · Infertility, Female · IVF · Pregnancy Early

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT04423211Phase 3Recruiting804 enrolled2020

    Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

    ECOG-ACRIN Cancer Research Group

    Biochemically Recurrent Prostate Carcinoma · Metastatic Prostate Carcinoma · Prostate Adenocarcinoma · Stage IVB Prostate Cancer AJCC v8

  • NCT04537078Phase 3Completed90 enrolled2020

    Progestin Primed Double Stimulation Protocol Versus Flexible GnRH Antagonist Protocol in Poor Responders

    El Shatby University Hospital for Obstetrics and Gynecology

    Infertility, Female

  • NCT04727684Phase 4Completed50 enrolled2020

    Effect of GnRH Agonist vs GnRH Antagonist on Oocyte Morphology in Polycystic Ovary Syndrome Patients During IVF/ICSI

    Damascus University

    In Vitro Fertilization · Infertility · Intracytoplasmic Sperm Injection · Polycystic Ovary Syndrome

  • NCT04724486Phase 4Completed50 enrolled2020

    Effect of GnRH Agonist vs GnRH Antagonist on Oocyte Morphology During IVF/ICSI

    Damascus University

    In Vitro Fertilization · Intracytoplasmic Sperm Injection · Infertility

  • NCT04600986Completed70 enrolled2020

    Repeated Doses of GnRH Agonist as Oocyte Triggering in Antagonist Protocol for Patients With Polycystic Ovary Syndrome

    Royan Institute

    Polycystic Ovary Syndrome

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT04407052Phase 2Unknown66 enrolled2020

    Double Trigger in Patients With Low Proportion of Mature Oocytes

    Riyadh Fertility and Reproductive Health center

    Infertility, Female

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT04407065Phase 2Unknown56 enrolled2020

    Double Trigger in Patients With Low Number of Oocytes Retrieved Per Number of Preovulatory Follicles

    Riyadh Fertility and Reproductive Health center

    Infertility, Female

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT05406999Phase 2Recruiting900 enrolled2020

    Neoadjuvant Intense Endocrine Therapy for High Risk and Locally Advanced Prostate Cancer

    The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

    Neoadjuvant Therapy · High Risk Prostate Cancer · Locally Advanced Prostate Cancer · Intense Endocrine Therapy

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT04248621Phase 4Unknown164 enrolled2020

    Androgen Deprivation Therapy on Bone Mineral Density Change in Prostate Cancer Patients

    Wonju Severance Christian Hospital

    Prostatic Neoplasms

  • NCT04854707Completed5,484 enrolled2020

    An Observational Study of Follitropin Alpha Biosimilar: the Real-world Data

    IVFarma LLC

    Reproductive Issues · Reproductive Disorder · Fertility Disorders · Fertility Issues

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT04181203Phase 3Active Not Recruiting490 enrolled2020

    Combined Apalutamide, Radiotherapy, and LHRH Agonist in Prostate Cancer Patients After Prostatectomy

    UNICANCER

    Prostate Cancer

  • NCT04724343Phase 4Completed50 enrolled2019

    Effect of GnRH Agonist vs GnRH Antagonist on IVF/ICSI Outcomes.

    Damascus University

    In Vitro Fertilization · Intracytoplasmic Sperm Injection · Infertility

  • NCT04727671Phase 4Completed50 enrolled2019

    Effect of GnRH Agonist vs GnRH Antagonist on IVF/ICSI Outcomes in Polycystic Ovary Syndrome Patients.

    Damascus University

    In Vitro Fertilization · Intracytoplasmic Sperm Injection · Infertility · Polycystic Ovary Syndrome

  • NCT04549649Completed52 enrolled2019

    The Effect of Dual Trigger for Final Oocyte Maturation on IVF/ICSI Outcomes in Patients With Suboptimal Ovarian Response

    Royan Institute

    Ovarian Stimulation · Reproductive Techniques, Assisted

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT04064840Phase 3Recruiting784 enrolled2019

    GnRH Agonist for Dual Trigger in IVF and for Luteal Phase Support in FET

    The University of Hong Kong

    Subfertility

  • NCT04189900Phase 1Completed2 enrolled2019

    Generation of Biological Samples Positive to Triptorelin for Anti-doping Control

    Parc de Salut Mar

    Healthy Volunteers

  • NCT03809000Phase 2Active Not Recruiting188 enrolled2019

    A Study of Salvage Radiotherapy With or Without Enzalutamide in Recurrent Prostate Cancer Following Surgery

    RTOG Foundation, Inc.

    Prostate Cancer

  • NCT03899077Phase 2Unknown202 enrolled2019

    Radiotherapy Combined With a LHRH (Ant)Agonist Versus Apalutamide in Patients With Biochemical Recurrence After RP

    Cancer Research Antwerp

    Cancer of Prostate

  • NCT03809221Phase 4Unknown1,892 enrolled2019

    The Effectiveness and Safety of the Prolonged Down-regulation Protocol for Controlled Ovarian Hyperstimulation

    Peking University People's Hospital

    Infertility, Female

  • NCT03944434Phase 2Active Not Recruiting116 enrolled2018

    FACILE: FeAsibility of First-line RiboCIclib in OLdEr Patients with Advanced Breast Cancer

    Fondazione Sandro Pitigliani

    Breast Cancer

  • NCT04869371Phase 2Unknown75 enrolled2018

    Androgen Deprivation Therapy Combined With Docetaxel for High Risk Prostate Cancer

    Hongqian Guo

    Neoadjuvant Therapy \ High Risk Prostate Cancer \ Docetaxel

  • NCT04174378Completed222 enrolled2018

    Luteal Phase Support In IVF Women Using GnRH Agonist

    National University of Malaysia

    IVF · Luteal Phase Defect

  • NCT03678025Phase 3Recruiting1,273 enrolled2018

    Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

    SWOG Cancer Research Network

    Castration Levels of Testosterone · Metastatic Prostatic Adenocarcinoma · Stage IV Prostate Cancer AJCC v8 · Stage IVA Prostate Cancer AJCC v8

  • NCT03349905Completed237 enrolled2018

    Deferred Versus Fresh Embryo Transfers

    Assistance Publique - Hôpitaux de Paris

    Infertility, Female

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT03536234Phase 2Unknown52 enrolled2018

    Efficacy and Safety of GnRH Analogue Triptorelin for HIV-1 Reservoir Reduction in ART Treated HIV-1 Infected Patients

    Immune System Regulation AB

    HIV-1-infection

  • NCT03511196Early Phase 1Active Not Recruiting17 enrolled2018

    Intermittent Androgen Deprivation Therapy for Stage IV Castration Sensitive Prostate Cancer

    H. Lee Moffitt Cancer Center and Research Institute

    Prostate Cancer · Stage IV Prostate Cancer · Advanced Prostate Cancer · Adenocarcinoma of the Prostate

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT03684824Unknown100 enrolled2018

    Accuracy of Ultrasound Markers Versus Biochemical Markers in Prediction of Ovarian Response in Obese Women Undergoing IVF/ICSI Treatment

    Cairo University

    Invitro Fertilization

  • NCT04224818Phase 3Completed140 enrolled2018

    Dual Trigger in the Final Oocyte Maturation in Poor Ovarian Responders

    American University of Beirut Medical Center

    Poor Ovarian Reserve

  • NCT03660813Completed200 enrolled2018

    Follicle Size and Oocyte Development

    Sheba Medical Center

    IVF Treatment

  • NCT03311555Phase 2Completed39 enrolled2018

    A Salvage Trial of AR Inhibition With ADT and Apalutamide With Radiation Therapy Followed by Docetaxel in Men With PSA Recurrent Prostate Cancer After Radical Prostatectomy (STARTAR)

    Andrew J. Armstrong, MD

    Prostate Cancer

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT03428919Completed1,064 enrolled2018

    ICSI Versus Conventional IVF in Non-male Factor Couples

    Mỹ Đức Hospital

    Infertility

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT04071574Phase 1/2Completed200 enrolled2018

    Comparative Study on the Efficacy of Ovarian Stimulation Protocols on the Success Rate of ICSI in Female Infertility

    Lebanese University

    Female Infertility · Female Infertility Due to Ovulatory Disorder · Premature Ovarian Failure · Polycystic Ovary Syndrome

  • NCT03291821Completed136 enrolled2017

    DuoStim in Cases of PGT: Comparison of Embryo Quantity and Embryonic Quality Using MitoScore

    IVI Madrid

    Infertility, Female

  • NCT02972060Phase 2Active Not Recruiting61 enrolled2017

    ODM-201 vs Androgen Deprivation Therapy in Hormone naïve Prostate Cancer

    European Organisation for Research and Treatment of Cancer - EORTC

    Prostate Cancer

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT03332797Phase 1Active Not Recruiting181 enrolled2017

    A Study of GDC-9545 Alone or in Combination With Palbociclib and/or Luteinizing Hormone-Releasing Hormone (LHRH) Agonist in Locally Advanced or Metastatic Estrogen Receptor-Positive Breast Cancer

    Genentech, Inc.

    Breast Cancer

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT03279250Phase 2Completed86 enrolled2017

    Apalutamide and Gonadotropin-Releasing Hormone Analog With or Without Abiraterone Acetate in Treating Participants With Prostate Cancer

    M.D. Anderson Cancer Center

    Prostate Adenocarcinoma · Stage IIB Prostate Cancer AJCC v8 · Stage IIC Prostate Cancer AJCC v8 · Stage IIIA Prostate Cancer AJCC v8

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT04659551Phase 2Completed43 enrolled2017

    Neoadjuvant Chemo-endocrine Therapy and Immunotherapy for Pre-menopausal Luminal B Breast Cancer Patients

    Istituto Oncologico Veneto IRCCS

    Breast Cancer

  • NCT03232281Phase 3Completed300 enrolled2017

    Study to Compare the Oestradiol Suppression, Clinical Efficacy and Safety of Two Formulations of Triptorelin (Triptorelin Pamoate PR 3-month and Triptorelin Acetate PR 1-month) in Chinese Subjects With Endometriosis

    Ipsen

    Endometriosis

  • NCT03192527Phase 1Unknown50 enrolled2017

    Single Dose Recombinant Human Follicle Stimulating Hormone Fc Husion Protein (KN015) in Healthy Volunteers

    Alphamab Jilin Co., Ltd.

    Infertility, Female

  • NCT03353883Phase 2/3Unknown200 enrolled2017

    Early Preparation With Gonadotropin- Releasing Hormon (GnRh) Agonists Injection With Frozen-Thawed Embryo Transfer?

    Benha University

    Infertility, Female

  • NCT03139474Phase 2/3Unknown120 enrolled2017

    Impact of Gonadotrophin Releasing Hormone Analogues on Oocyte and Embryo Quality

    Assiut University

    Infertility, Female

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT03118830Phase 4Completed204 enrolled2017

    Long Protocol and Freeze All Embryos vs Antagonist Protocol With Fresh Embryo Transfer in PCOS Patients Undergoing ICSI

    Cairo University

    Invitro Fertilization

  • NCT03169166Phase 4Completed277 enrolled2017

    The Use of GnRH Agonist Trigger for Final Follicle Maturation in Women Undergoing Assisted Reproductive Technologies

    American University of Beirut Medical Center

    Sterility · Infertility

  • NCT03071172Phase 3Unknown252 enrolled2017

    Clinical Study of Recombinant Human Follitropin for Injection Assisted in COH Assisted IVF-ET

    Changchun GeneScience Pharmaceutical Co., Ltd.

    Ovarian Hyperstimulation Syndrome

  • NCT02715232Phase 4Unknown92 enrolled2017

    Effects of Sex Steroids on the Serotonin System

    Medical University of Vienna

    Gender Dysphoria

  • NCT02821819Phase 4Terminated15 enrolled2017

    Random-start Ovarian Stimulation in Egg-donors (ROSE)

    Instituto Bernabeu

    Infertility

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT02979886Unknown1,500 enrolled2017

    Effects of SNP of GnRH Receptor Genes in IVF Patients

    Miao benyu

    Infertility, Female

  • NCT03115307Phase 4Completed167 enrolled2017

    Luteal Phase Support in Insemination Cycles

    Tampere University Hospital

    Infertility, Female

  • NCT03005275Withdrawn2017

    A Comparison of Cost - Effectiveness of Stimulated ICSI and IVM Strategy in PCOS Women

    Vietnam National University

    Infertility

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT06473259Recruiting3,000 enrolled2016

    Evaluation of Clinical Outcomes of Chemotherapy or Androgen-receptor Targeting Agent (Alone or Combined) or Radiotherapy on Primary Tumor in Addition to Androgen Deprivation Therapy in HOrmone-Sensitive Metastatic Prostate Cancer Patients

    Santa Chiara Hospital

    Prostate Cancer · Hormone Sensitive Prostate Cancer · Metastatic Tumor

  • NCT02940535Unknown200 enrolled2016

    Low Dose GnRHa Early Luteal Phase Down Regulation Versus GnRHa Ultra-short Protocol for Poor Ovarian Response

    Navy General Hospital, Beijing

    Subfertility, Female · Ovulation Disorder

  • NCT04846218Completed100 enrolled2016

    Agonist Trigger With HCG Luteal Supplementation vs HCG Trigger With Progesterone Luteal Supplementation in Antagonist Controlled HyperstimulationCycle

    Ain Shams University

    Infertility, Female

  • NCT02856048Phase 2/3Unknown11 enrolled2016

    Co-treatment With GnRH Analogs on the Ovarian Reserve in Young Women Treated With Alkylating Agents for Cancer

    Assistance Publique - Hôpitaux de Paris

    Cancer · Toxicity Due to Chemotherapy · Sarcoma · Osteosarcoma

  • NCT02685397Phase 2/3Active Not Recruiting102 enrolled2016

    Management of Castration-Resistant Prostate Cancer with Oligometastases

    Sir Mortimer B. Davis - Jewish General Hospital

    Castration-resistant Prostate Cancer Patients with Oligometastases

  • NCT02312076Phase 4Unknown200 enrolled2016

    GnRHa for Luteal Phase Support in Long GnRHa Protocol Cycles

    Mansoura University

    Infertility

  • NCT02862782Phase 3Unknown1,000 enrolled2016

    Combination of Gonadotropin-releasing Hormone Agonist and Human Chorionic Gonadotropin Triggered by Normal Responder in GnRH-antagonist Cycles

    Tel-Aviv Sourasky Medical Center

    In-vitro Fertilization

  • NCT02908438Phase 1Unknown400 enrolled2016

    Gonadotrophin Releasing Hormone Agonist Addition for Luteal Support in In-vitro Fertilization and Embryo Transfer Cycles

    Northwest Women's and Children's Hospital, Xi'an, Shaanxi

    GnRHa;LPS

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • ISRCTN4583504125 enrolled2016

    A new treatment protocol reducing the risk of implantation failure and early pregnancy loss after transfer of embryos resulting from in vitro fertilisation

    MARGen Clinic

    Luteal phase insufficiency in assisted reproduction

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT02741154Phase 4Completed50 enrolled2016

    Role of Aromatase Inhibitor to Enhance Ovulation in Poor Responder During Induction With Short Antagonist Protocol in Cases of ICSI

    Minia University

    Infertility Indicated for ICSI

  • NCT02312089Phase 4Unknown200 enrolled2016

    GnRHa for Luteal Phase Support in GnRH Antagonist Protocol Cycles

    Mansoura University

    Infertility

  • NCT02827656Unknown50 enrolled2016

    Comapring Luteal Phase Support in IVF Patients Who Are at High Risk for Developing OHSS

    Meir Medical Center

    Infertility

  • NCT04008966Phase 4Completed160 enrolled2016

    Comparative Study Between Single Versus Dual Trigger for Poor Responders in GnRH-antagonist ICSI Cycles

    Cairo University

    Assisted Reproduction

  • NCT02825290Phase 4Unknown62 enrolled2016

    Modified Luteal Support for Frozen-Thawed Embryo Transfer - A Prospective Study

    Sheba Medical Center

    Embryo Transfer · Luteal Support

  • NCT02330770Phase 4Unknown225 enrolled2016

    Dual Trigger Versus GnRHa Trigger Combined With Luteal HCG Administration

    Mansoura University

    Infertility

  • NCT02737800Completed88 enrolled2016

    Effect of Prolonged GnRh Agonists on Results of Intracytoplasmic Sperm Injection (ICSI ) in Endometrioma Patients

    Kasr El Aini Hospital

    Endometrioma

  • NCT02736032Phase 3Completed310 enrolled2016

    Cryopreserved-thawed Embryo Transfer With or Without Gonadotropin Releasing Hormone Agonist

    Cairo University

    Infertility

  • NCT02681536Unknown200 enrolled2016

    Miniflare Versus Long Protocol in Poor Responders

    Woman's Health University Hospital, Egypt

    Infertility

  • NCT02673632Unknown30 enrolled2016

    The Influence of AMH on Ovarian Responsiveness to Ovulation Induction With GnRH in Women With PCOS

    Ain Shams Maternity Hospital

    Infertility

  • NCT02635607Unknown200 enrolled2016

    Effectiveness and Safety Study of Fixed Versus Flexible of Gonadotropin-releasing Hormone Antagonist Protocol

    Chong Qing Reproducive and Genetic Institute

    Infertility

  • NCT02588404Withdrawn2015

    The Predictive Value of TMPRSS2-ERG Fusion in High Risk Prostate Cancer Patient

    Sir Mortimer B. Davis - Jewish General Hospital

    Prostate Cancer

  • NCT02655146Phase 4Unknown700 enrolled2015

    the Effects of GnRHa Add up to Routine Luteal Phase Support on Frozen Embryo Implantation in Frozen Embryo Transfer .

    Chong Qing Reproducive and Genetic Institute

    Infertility

  • NCT02625532Unknown60 enrolled2015

    Early Follicular Phase vs Lutheal Phase Ovarian Stimulation in Bologna Criteria IVF/ICSI Cycles (LUTEAL Trial)

    Instituto Bernabeu

    Reproductive Techniques, Assisted

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT02278185Phase 2Completed19 enrolled2015

    Enzalutamide Versus Standard Androgen Deprivation Therapy for the Treatment Hormone Sensitive Prostate Cancer

    University of Colorado, Denver

    Adenocarcinoma of the Prostate · Recurrent Prostate Cancer · Stage III Prostate Cancer · Stage IV Prostate Cancer

  • NCT01969578Phase 2Completed149 enrolled2015

    Androgen Deprivation Therapy in Advanced Salivary Gland Cancer

    European Organisation for Research and Treatment of Cancer - EORTC

    Salivary Gland Cancer

  • NCT02742675Phase 2Unknown200 enrolled2015

    Androgen Deprivation Therapy or Androgen Deprivation Therapy Plus Definitive Treatment (Radiation or Surgery)

    Fudan University

    Prostate Cancer

  • NCT02366494Completed42 enrolled2015

    Micro RNAs to Predict Response to Androgen Deprivation Therapy

    Medical College of Wisconsin

    Prostate Cancer

  • NCT02418572Phase 3Terminated290 enrolled2015

    Testosterone TRANSdermal Gel for Poor Ovarian Responders Trial

    Fundacion Dexeus

    Infertility · Poor Ovarian Response

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT02429999Phase 2Unknown80 enrolled2015

    Letrozole in Assisted Reproductive Technology

    Assiut University

    to Evaluate Letrozole as a Modality for Minimal Ovarian Stimulation in ICSI Cycles .

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT02338206Phase 2Completed240 enrolled2015

    Long Protocol and Growth Hormone in Poor Responders

    Woman's Health University Hospital, Egypt

    Infertility

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT02368964Completed100 enrolled2015

    IVF Treatment in Women With Immature Oocytes in Previous Cycle

    Sheba Medical Center

    Infertility

  • NCT02346253Completed146 enrolled2015

    High-Dose Brachytherapy in Treating Patients With Prostate Cancer

    Stanford University

    Prostate Adenocarcinoma · Stage I Prostate Cancer · Stage IIA Prostate Cancer · Stage IIB Prostate Cancer

  • NCT02477566Unknown200 enrolled2014

    Comparative Study of Long-acting and Short Acting Triptorelin in PCOS Patients Who Underwent IVF/ICSI

    Nanjing University

    In Vitro Fertilization · Polycystic Ovary Syndrome

  • NCT02813239Completed81 enrolled2014

    Dual Triggering in Patients With a High Immature Oocyte Rate

    IVI Madrid

    INFERTILITY

  • NCT02048891Phase 4Completed3 enrolled2014

    Ovulation Trigger With hCG Compared to GnRH Agonist in Patients With Repeated IVF Failures

    Rambam Health Care Campus

    Infertility

  • NCT03954197Unknown204 enrolled2014

    Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients

    Hôpital Jean Verdier

    Fertility Preservation · Breast Cancer

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT02244151Phase 2Completed130 enrolled2014

    Evaluation of Time Interval Between Ovulation Trigger With Triptorelin Acetate and Oocyte Retrieval

    Instituto de Investigacion Sanitaria La Fe

    Female Urogenital Diseases

  • NCT02732808Phase 3Completed50 enrolled2014

    Dual Ovarian Stimulation in the Same IVF/ICSI Cycles for Treatment of Poor Ovarian Responders

    Royan Institute

    Infertility

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT02208986Completed165 enrolled2014

    GnRHa Trigger in Asian Oocyte Donors- a Dose Finding Study

    Vietnam National University

    Normal Oocyte Donors

  • NCT02185326Phase 4Completed145 enrolled2014

    Microflare Protocol in Poor Responders

    Woman's Health University Hospital, Egypt

    Female Infertility Due to Diminished Ovarian Reserve

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT02168062Phase 2Terminated57 enrolled2014

    Supportive Therapy in Androgen Deprivation Clinic in Improving Health Outcomes and Managing Side Effects in Patients With Prostate Cancer

    University of California, San Francisco

    Prostate Adenocarcinoma

  • NCT05800197Unknown300 enrolled2014

    Neoadjuvant Endocrine Therapy in Breast Cancer. Real Clinical Practice in Russia

    Blokhin's Russian Cancer Research Center

    Breast Cancer · Neoadjuvant Endocrine Therapy

  • NCT02102646Phase 4Completed31 enrolled2014

    MRI Substudy; Metabolic Changes Due to Iatrogenic Hypogonadism

    Herlev Hospital

    Prostate Cancer · Metabolic Syndrome · Hypogonadism · Fatty Liver

  • NCT03039049Phase 3Completed328 enrolled2014

    GNRH Agonist Trigger and Modified Luteal Phase Adding a Bolus of GnRHa at the Time of Implantation: a RCT

    Centre Hospitalier Universitaire Ibn Rochd

    Infertility

  • NCT02053779Phase 3Completed328 enrolled2014

    GnRH Agonist Trigger and Modified Luteal Phase Support, Adding a Bolus of GnRHa at the Time of Implantation - a RCT

    Centre Hospitalier Universitaire Ibn Rochd

    Infertility

  • NCT01973842Phase 2Unknown90 enrolled2014

    Evaluation of the Optimal Dose of GnRH Agonist for Triggering Final Oocyte Maturation in High Risk OHSS Patients

    Aristotle University Of Thessaloniki

    Subfertility

  • NCT02005887Phase 2Completed51 enrolled2014

    TRial on the Endocrine Activity of Neoadjuvant Degarelix

    ETOP IBCSG Partners Foundation

    Breast Cancer Invasive Nos

  • NCT02201914Phase 4Unknown250 enrolled2014

    Clomiphene Citrate Plus Gonadotropins and GnRH Antagonist Versus Flexible GnRH Antagonist Protocol Versus Microdose GnRH Agonist Protocol in Poor Responders Undergoing IVF

    Bioroma

    Poor Responders · IVF · Clomiphene Citrate · GnRH Agonist

  • NCT02144818Unknown60 enrolled2014

    GnRH Agonist Triggering Supplemented With Hcg in Women With Poor Ovarian Response

    Sheba Medical Center

    Women With Poor Ovarian Response

  • NCT02070198Phase 4Unknown120 enrolled2013

    Long Acting FSH Plus Antagonist Versus Daily FSH Plus Antagonist Versus Short Agonist Protocol in Poor Responders Undergoing IVF

    Bioroma

    Female Infertility · Poor Responder

  • NCT02238366Completed368 enrolled2013

    Study To Assess Renewal Of Treatment In Patients Recently Diagnosed With Prostate Cancer

    Ipsen

    Prostate Cancer

  • NCT01979341Withdrawn2013

    The Effect of a Dual Trigger on Intracytoplasmic Sperm Injection (ICSI) Reproductive Outcomes

    Antalya IVF

    Pregnancy · Ovarian Hyperstimulation Syndrome

  • NCT01942369Completed402 enrolled2013

    A Study to Describe the Efficacy of Diphereline Following Conservative Surgery in Deep Infiltrating Endometriosis (DIE) Patients Over a Period of 24 Months

    Ipsen

    Deep Infiltrating Endometriosis (DIE)

  • NCT01926210Phase 4Unknown500 enrolled2013

    Comparison of Ovarian Mild Stimulation and Controlled Ovarian Stimulation in Poor Ovarian Responders

    Huang Rui

    Infertility

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT01897324Phase 4Completed287 enrolled2013

    IVF/ICSI Protocols in Poor Responders With Growth Hormone

    Woman's Health University Hospital, Egypt

    Female Infertility Due to Diminished Ovarian Reserve

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT02400801Completed166 enrolled2013

    Gonadotropin-releasing Hormone (GnRH) Downregulation Versus Oral Anticonception Prior to ART in Postoperative Endometriosis Patients

    Universitaire Ziekenhuizen KU Leuven

    Endometriosis · Infertility

  • NCT02113553Phase 2Terminated45 enrolled2013

    Anti-Mullerian Hormone (AMH) as Marker of Ovarian Reserve

    Armando Santoro, MD

    Breast Cancer

  • NCT02620124Phase 4Completed100 enrolled2013

    GnRH Agonist as Luteal Support in FET Cycles

    Turku University Hospital

    Infertility

  • NCT02461875Phase 2Unknown236 enrolled2013

    Cabergoline Versus GnRH Antagonist Rescue and Cabergoline in the Prevention of Ovarian Hyperstimulation Syndrome

    Aljazeera Hospital

    OHSS

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT01790126Phase 2Completed90 enrolled2013

    The Role of Highly Selective Androgen Receptor (AR) Targeted Therapy in Men With Biochemically Relapsed Hormone Sensitive Prostate Cancer

    Aragon Pharmaceuticals, Inc.

    Prostate Cancer

  • NCT01790282Completed220 enrolled2013

    Is Adding E2 to P4 Luteal Support In High Responder Long Gn-RH Agonist ICSI Cycles Detrimental to Outcome? RCT

    Mansoura Integrated Fertility Center

    IVF · Infertility

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT01798862Phase 2/3Completed100 enrolled2013

    Endometrial Injury and IVF Outcome Parameters in Patients With Failed IVF Cycles

    National and Kapodistrian University of Athens

    Repeated Implantation Failures

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT03837223Completed271 enrolled2013

    RESCUE PROTOCOL AND FRESH EMBRYO TRANSFER

    Istituto Clinico Humanitas

    GnRH Trigger and Rescue Protocol

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT01715129Phase 3Completed126 enrolled2013

    Induction and Maintenance of Castration After Subcutaneous Injections of Triptorelin Pamoate in Patients With Prostate Cancer

    Ipsen

    Prostate Cancer

  • NCT01873378Completed84 enrolled2013

    GnRH Agonist Pretreatment in Hysteroscopic Myomectomy

    Azienda Ospedaliera S. Maria della Misericordia

    Uterine Myoma

  • NCT01753297Phase 4Completed226 enrolled2012

    A Study of Immediate 9 Months Adjuvant Hormone Therapy With Triptorelin 11.25 mg Versus Active Surveillance After Radical Prostatectomy in High Risk Prostate Cancer Patients.

    Ipsen

    Prostate Cancer

  • NCT01714648Phase 4Terminated6 enrolled2012

    Can GnRH Agonist Trigger Prevent Ovarian Hyperstimulation Syndrome?

    Elisha Hospital

    Ovarian Hyperstimulation Syndrome

  • NCT01638026Phase 4Completed93 enrolled2012

    Final Oocyte Maturation Via Administration of GnRH Agonists Followed By Luteal Support With hCG

    HaEmek Medical Center, Israel

    Infertility

  • NCT03397537Phase 2Completed46 enrolled2012

    Neoadjuvant Endocrine Therapy in Breast Cancer

    Guangdong Provincial People's Hospital

    Highly Endocrine Responsive Operable Breast Cancer

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT01673984Phase 4Terminated27 enrolled2012

    GP Extended Action Triptorelin

    Ipsen

    Prostate Cancer

  • NCT01732068Phase 2Completed51 enrolled2012

    Treatment of Poor Ovarian Responders With Corifollitropin Alfa Followed by hpHMG in a Short GnRH Agonist Protocol

    Universitair Ziekenhuis Brussel

    Infertility · Poor Ovarian Response

  • NCT02022228Unknown200 enrolled2012

    Dual Trigger to Reduce Ovarian Hyperstimulation Syndrome

    Chenshiling

    Infertility and at High Risk of OHSS

  • NCT02022241Unknown80 enrolled2012

    Repeated Injection of GnRH Agonist to Reduce Ovarian Hyperstimulation Syndrome

    Chenshiling

    Infertility and at High Risk of OHSS

  • NCT01732094Phase 2Completed57 enrolled2012

    Corifollitropin Alfa Followed by hpHMG in a Long GnRH Agonist Protocol for the Treatment of Poor Ovarian Responders

    Universitair Ziekenhuis Brussel

    Infertility · Poor Ovarian Response

  • NCT01656161Phase 3Completed120 enrolled2012

    Study on Efficacy, Pharmacokinetics, and Safety of Two Subcutaneous Injections of Triptorelin Embonate 6 Month Formulation in Patients With Advanced Prostate Cancer

    Debiopharm International SA

    Prostate Cancer

  • NCT01634724Unknown96 enrolled2012

    GnRH Agonist (GnRHa) Withdrawal at Late Stage of Long Protocol and the Incidence of Ovarian Hyper-stimulation

    Nanjing University

    Infertile High-risk Patients With Polycystic Ovaries

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT02674178Phase 4Completed235 enrolled2012

    FSH/LH Ratio as a Predictor of IVF Outcome in Young and Older Women

    Cairo University

    Invitro Fertilization

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT01546987Phase 3Completed239 enrolled2012

    Hormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Treating Patients With High-Risk Prostate Cancer

    Radiation Therapy Oncology Group

    Prostate Cancer

  • NCT01467882Phase 3Completed44 enrolled2012

    Efficacy, Safety, and Pharmacokinetics (PK) of Triptorelin 6-month Formulation in Patients With Central Precocious Puberty

    Debiopharm International SA

    Central Precocious Puberty

  • NCT01565265Completed5 enrolled2012

    Comparing Ovarian Stimulation for Assisted Reproduction With Two Different Forms of Pituitary Suppression

    University Hospital, Basel, Switzerland

    Female Infertility Due to Nonimplantation of Ovum · Complications Associated With Artificial Fertilization

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT01581359Phase 4Completed200 enrolled2012

    The Effect of Pre-treatment With GnRH Analogues Prior in Vitro Fertilization in Patients With Endometriosis

    Instituto de Investigacion Sanitaria La Fe

    Endometriosis · Infertility

  • ISRCTN98623456Stopped160 enrolled2012

    Comparison study of Puregon® and Elonva® used in a long gonadotropin-releasing hormone (GnRH) agonist protocol for IVF stimulation

    Leuven Institute for Fertility and Embryology [LIFE] (Belgium)

    Female infertility

  • NCT01492972Phase 3Recruiting192 enrolled2012

    Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer

    Proton Collaborative Group

    Prostate Cancer

  • NCT01590173Phase 2/3Completed86 enrolled2012

    Addition of Prednisolone and Heparin in Patients Undergoing IVF With Failed IVF Cycles

    National and Kapodistrian University of Athens

    Infertility

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT01607203Phase 4Completed120 enrolled2011

    Trial Comparing hCG Triggering Versus hCG Associated With GnRH Agonist

    AZ Jan Palfijn Gent

    Infertility

  • NCT01374087Phase 2Terminated32 enrolled2011

    Study to Assess the Efficacy of Brachytherapy With or Without Hormone Therapy, Using Triptorelin 22.5mg in Patients With Recurrence of Prostate Cancer

    Ipsen

    Prostate Cancer

  • NCT01500863Phase 4Completed35 enrolled2011

    Endometrial Receptivity After GnRH Agonist Triggering

    IVI Madrid

    Ovarian Hyperstimulation Syndrome

  • NCT01468441Completed96 enrolled2011

    Ovarian Stimulation Using Recombinant Follicle-stimulating Hormone (FSH) and Gonadotrophin Releasing Hormone (GnRH) Agonist in Alternate Days

    Fertility - Assisted Fertilization Center

    Infertility

  • NCT01402336Phase 3Completed43 enrolled2011

    GnRH Antagonist Versus GnRH Agonist in Polycystic Ovary Syndrome During in Vitro Fertilization - Embryo Transfer

    Seoul National University Hospital

    Infertility · Polycystic Ovary Syndrome

  • NCT01313273Phase 3Terminated3 enrolled2011

    Study of Lanreotide in Non Metastatic Castration-resistant Prostate Cancer Patients

    Ipsen

    Prostate Cancer

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT01353846Phase 4Unknown70 enrolled2011

    Comparison Between Natural and Artificial Cycle in Recipient Oocyte Patients

    Instituto Valenciano de Infertilidad, IVI VALENCIA

    Infertility

  • ISRCTN7279387872 enrolled2011

    Effect of Decapeptyl® on prostate Volume pre-RadioTherapy

    University Hospitals Bristol NHS Foundation Trust (UK)

    Prostate cancer patients who are due to undergo radical radiotherapy to the prostate

  • NCT02342197Phase 3Completed60 enrolled2011

    Comparative Study Between Minidose Long Protocol and Microdose Flare Protocol in Controlled Ovarian Hyperstimulation

    Kasr El Aini Hospital

    Infertility

  • NCT01257425Phase 2Completed109 enrolled2010

    Equivalence of Intramuscular (IM) Versus Subcutaneous (SC) Applications of Long Acting Pamorelin 11.25 mg

    Ipsen

    Prostate Cancer

  • NCT01206803Completed294 enrolled2010

    Ovarian Response Prediction in In Vitro Fertilization (IVF) Patients

    University Hospital Schleswig-Holstein

    Infertility, Subfertility

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT01888744Phase 4Completed120 enrolled2010

    Preimplantation Genetic Diagnosis (PGD) With Gonadotropin-releasing Hormone (GnRH) Agonist Versus Antagonist

    Universitair Ziekenhuis Brussel

    Reproductive Endocrinology · Fertility · Optimal Stimulation Protocol

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT01161563Phase 4Completed118 enrolled2010

    Randomized Crossover Trial to Assess the Tolerability of Gonadotropin Releasing Hormone (GnRH) Analogue Administration

    Watson Pharmaceuticals

    Prostate Cancer

  • ISRCTN137739044,435 enrolled2010

    In vitro culture and transfer of human embryos

    Cologne University Maternal Hospital (Germany)

    In vitro fertilization

  • NCT01278290Phase 3Completed46 enrolled2009

    Comparative Validation of the Triptorelin Test for the Diagnosis of CPP in Girls

    Hospital de Niños R. Gutierrez de Buenos Aires

    Central Precocious Puberty · Sexual Precocity

  • NCT01020448Phase 3Completed339 enrolled2009

    Effect of Triptorelin (Decapeptyl®) 22.5 mg on Two Biomarkers in Patients With Advanced Prostate Cancer

    Ipsen

    Prostate Cancer

  • NCT00936390Phase 3Completed1,538 enrolled2009

    Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer

    Radiation Therapy Oncology Group

    Prostate Cancer

  • NCT00963417Completed119 enrolled2009

    Study of Bone Mineral Density in Women With Breast Cancer Treated With Triptorelin and Tamoxifen or Exemestane on Protocol IBCSG 25-02

    ETOP IBCSG Partners Foundation

    Breast Cancer · Osteoporosis

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT01157754Completed115 enrolled2009

    Oral Contraceptive Pill and GnRH Antagonist Versus Long Protocol in IVF Patients

    IVI Madrid

    Infertility

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • ISRCTN1904057740 enrolled2008

    A prospective single-centre single-arm open-label study of the long-term use of a LHRH agonist (Decapeptyl SR 11.25mg) in combination with livial add-back therapy in the management of chronic cyclical pelvic pain in pre-menopausal women

    Sheffield Teaching Hospitals NHS Trust (UK)

    Topic: Reproductive Health and Childbirth; Subtopic: Reproductive Health and Childbirth (all Subtopics); Disease: Reproductive Health & Childbirth

  • NCT00735852Phase 4Completed31 enrolled2008

    Decapeptyl SR With Livial Add Back Therapy in the Management of Chronic Cyclical Pelvic Pain in Pre Menopausal Women

    Sheffield Teaching Hospitals NHS Foundation Trust

    Endometriosis

  • NCT00975676Completed123 enrolled2008

    Study of Estrogen Levels in Premenopausal Women Who Have Undergone Surgery for Breast Cancer and Are Receiving Triptorelin and Tamoxifen Citrate or Exemestane on Clinical Trial IBCSG 24-02

    ETOP IBCSG Partners Foundation

    Breast Cancer

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT00866008Phase 4Terminated34 enrolled2008

    A Study of the Effects of a Novel Ovarian Stimulation Regimen on Embryo Aneuploidy Rates in In Vitro Fertilization (IVF)

    Bart CJM Fauser

    In Vitro Fertilization

  • NCT01389713Completed289 enrolled2008

    Clomifene Citrate as First Line Treatment in in Vitro Fertilization Cycles for Patients With Lower Ovarian Reserve

    Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

    Infertility

  • ISRCTN4504988990 enrolled2008

    A study to determine whether a single hormone injection a month before insertion of the contraceptive implant will reduce or stop irregular vaginal bleeding

    University Hospitals of Leicester NHS Trust (UK)

    Contraception, vaginal bleeding

  • NCT00848185Completed96 enrolled2008

    Differential Regulation of VEGF, Cadherin, Angiopietin 2 by Trigger Oocyte Maturation With GnRHa vs hCG in Donors

    IVI Madrid

    Vascular Endothelial Growth Factor Overexpression

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT00667069Phase 3Completed424 enrolled2008

    Triptorelin and Radiation Therapy in Treating Patients Who Have Undergone Surgery for Intermediate-Risk Stage III or Stage IV Prostate Cancer

    UNICANCER

    Prostate Cancer

  • NCT00909844Phase 3Completed35 enrolled2008

    Effects of Triptorelin Pamoate in Children With Precocious Puberty - Follow up Study

    Ipsen

    Precocious Puberty

  • ISRCTN5882834170 enrolled2008

    Clomiphene Citrate for Poor Responder women undergoing in vitro fertilisation (IVF)/intracytoplasmic sperm injection (ICSI) treatment cycles

    Egyptian International Fertility and IVF Center (EIFC) (Eygpt)

    Poor ovarian response

  • NCT00528866Phase 2Completed80 enrolled2008

    Radiation Therapy, Androgen Suppression, and Docetaxel in Treating Patients With High-Risk Prostate Cancer Who Have Undergone Radical Prostatectomy

    Radiation Therapy Oncology Group

    Prostate Cancer

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT01125488Phase 3Unknown80 enrolled2008

    Maintenance Therapy of Levonorgestrel-releasing Intrauterine System (LNG-IUS) to Prevent the Recurrence of Symptomatic Endometriosis After Conservative Surgery

    Taipei Veterans General Hospital, Taiwan

    Endometriosis

  • NCT00567580Phase 3Unknown1,792 enrolled2008

    Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising Prostate Specific Antigen (PSA) After Surgery for Prostate Cancer

    Radiation Therapy Oncology Group

    Prostate Cancer

  • NCT00840944Phase 4Unknown44 enrolled2008

    A 4 Year Combination Therapy of Growth Hormone and (GnRH) Agonist in Children With a Short Predicted Height

    Belgian Study Group for Pediatric Endocrinology

    Idiopathic Short Stature

  • ISRCTN0236516850 enrolled2007

    Efficacy and safety of Decapeptyl® SR by subcutaneous injection in patients with a diagnosis of prostate cancer

    University Hospitals Bristol NHS Foundation Trust (UK)

    Topic: Renal and Urogenital, National Cancer Research Network; Subtopic: Renal and Urogenital (all Subtopics); Disease: Urogenital

  • NCT00659373Phase 3Completed86 enrolled2007

    Brain Function in Premenopausal Women Receiving Tamoxifen With or Without Ovarian Function Suppression for Early-Stage Breast Cancer on Clinical Trial IBCSG 24-02

    ETOP IBCSG Partners Foundation

    Breast Cancer · Fatigue · Sleep Disorders

  • NCT00542126Unknown2007

    Luteal-Phase GnRH Agonist Administration in Frozen-Thawed IVF Embryo Transfer Cycles

    Shaare Zedek Medical Center

    Pregnancy Rate

  • NCT00564850Phase 3Completed37 enrolled2007

    Efficacy and Safety Study of Pamoate of Triptorelin in Children With Precocious Puberty

    Ipsen

    Precocious Puberty

  • ISRCTN42536405200 enrolled2007

    Can a dopamine agonist prevent severe ovarian hyperstimulation syndrome (OHSS) in women undergoing intracytoplasmic sperm injection (ICSI) treatment cycles?

    Samir Abbas Center (Saudi Arabia)

    Ovarian hyperstimulation syndrome (OHSS)

  • NCT00725491Phase 3Completed259 enrolled2007

    A Study to Assess the Efficacy and Safety of Ganirelix (Orgalutran®) Treatment in Chinese Women Undergoing Controlled Ovarian Stimulation for in Vitro Fertilization (IVF) or Intra Cytoplasmatic Sperm Injection (ICSI) (Study 38651)(P05703)

    Organon and Co

    Controlled Ovarian Stimulation

  • NCT00444639Phase 2Terminated25 enrolled2007

    Study to Assess the Non-inferiority of Pamorelin® 11,25mg SC Injected Versus Pamorelin® 11,25mg IM Injected in Patients Suffering From Advanced Prostate Cancer (PAMOJECT)

    Ipsen

    Prostate Cancer

  • ISRCTN81574253264 enrolled2007

    Brain development, brain functioning, growth and metabolic aspects in the clinical management of transsexual adolescents

    Vrije University Medical Centre (VUMC) (The Netherlands)

    Transsexuality

  • NCT00415246Phase 3Terminated100 enrolled2006

    Study to Evaluate a Subcutaneous Four Months Sustained-release Formulation of Triptorelin in Patients With Prostate Cancer

    Ipsen

    Prostate Cancer

  • NCT00516490Completed570 enrolled2006

    GnRH Agonist Administration in the Luteal Phase of ICSI-ET Cycles

    V.K.V. American Hospital, Istanbul

    Infertility

  • NCT01007851Phase 3Terminated2006

    Single Dose Gonadotropin-releasing Hormone (GnRH) Agonist Administration in the Luteal Phase of GnRH Antagonist Stimulated ICSI-ET Cycles

    V.K.V. American Hospital, Istanbul

    Infertility

  • NCT00751790Phase 3Completed120 enrolled2006

    Efficacy and Safety of a Triptorelin 6-month Formulation in Patients With Advanced Prostate Cancer

    Debiopharm International SA

    Prostatic Neoplasm

  • NCT00702520Completed15 enrolled2006

    Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established in Clinical Trial 38833 (P05783)

    Organon and Co

    Pregnancy · Neonates

  • NCT00417183Phase 4Unknown300 enrolled2005

    Comparison of the Long GnRH Agonist Protocol and the Flexible GnRH Antagonist Protocol of Ovarian Stimulation

    Eugonia

    Infertility

  • NCT00375687Unknown61 enrolled2005

    Investigation of Early Hormonotherapy Efficacy of Prostate Cancer

    Kaunas University of Medicine

    Prostate Cancer

  • NCT00194792Phase 2Terminated28 enrolled2005

    Hormone Therapy and Combination Chemotherapy Before and After Surgery in Treating Patients With Stage I-IIIA Breast Cancer

    University of Washington

    Estrogen Receptor-positive Breast Cancer · HER2-negative Breast Cancer · Progesterone Receptor-positive Breast Cancer · Stage I Breast Cancer

  • NCT00461916Phase 4Completed182 enrolled2005

    Half-Dose Depot Triptorelin Versus Reduced-Dose Daily Buserelin

    Tehran University of Medical Sciences

    Infertility

  • NCT00985062Completed54 enrolled2004

    Mild Versus Conventional Ovarian Stimulation Treatment for In Vitro Fertilization

    Erasmus Medical Center

    Subfertility

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT00090844Phase 2Terminated49 enrolled2004

    Triptorelin for Preserving Ovarian Function in Premenopausal Women Receiving Chemotherapy for Early-Stage Breast Cancer

    University of South Florida

    Breast Cancer · Hormone Changes · Drug Toxicity

  • NCT00412022Phase 3Unknown1,294 enrolled2004

    HOBOE: A Phase 3 Study of Adjuvant Triptorelin and Tamoxifen, Letrozole, or Letrozole and Zoledronic Acid in Premenopausal Patients With Breast Cancer.

    National Cancer Institute, Naples

    Breast Cancer

  • NCT00635258Completed100 enrolled2004

    Administration of GnRH Antagonist to Oocyte Donation Recipients

    Centro Ginecologia y Obstetricia.

    Pregnancy · Embryo Implantation

  • NCT01764230Completed72 enrolled2004

    Prevention of Ovarian Function Damage by a GnRH Analogue During Chemotherapy in Hodgkin Lymphoma Patients

    Masaryk University

    Hodgkin Lymphoma · Hodgkin Disease

  • NCT00066690Phase 3Completed3,066 enrolled2003

    Suppression of Ovarian Function With Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer

    ETOP IBCSG Partners Foundation

    Estrogen Receptor Positive Breast Cancer · Progesterone Receptor Positive Tumor · Recurrent Breast Carcinoma · Stage IA Breast Cancer

  • NCT00066703Phase 3Completed2,672 enrolled2003

    Triptorelin With Either Exemestane or Tamoxifen in Treating Premenopausal Women With Hormone-Responsive Breast Cancer

    ETOP IBCSG Partners Foundation

    Breast Cancer

  • NCT00417144Phase 4Unknown200 enrolled2003

    Comparison Between GnRH Agonist and GnRH Antagonist Protocols of Ovarian Stimulation in PCOS Patients

    Eugonia

    Polycystic Ovary Syndrome · Ovarian Hyperstimulation Syndrome

  • NCT00104741Phase 3Completed378 enrolled2003

    Triptorelin, Flutamide, and External-Beam Radiation Therapy or External-Beam Radiation Therapy Alone in Treating Patients With Stage II or Stage III Prostate Cancer

    UNICANCER

    Prostate Cancer

  • NCT00311636Phase 3Completed280 enrolled2003

    Triptorelin in Preventing Early Menopause in Premenopausal Women Who Are Receiving Chemotherapy for Stage I, Stage II, or Stage III Breast Cancer That Has Been Removed By Surgery

    Gruppo Italiano Mammella (GIM)

    Breast Cancer

  • NCT00417066Phase 4Completed270 enrolled2003

    Flexible GnRH Antagonist vs Flare up GnRH Agonist Protocol in Poor Responders

    Eugonia

    Infertility · Premature Ovarian Failure

  • NCT00066807Phase 3Terminated29 enrolled2003

    Premenopausal Endocrine Responsive Chemotherapy Trial

    ETOP IBCSG Partners Foundation

    Breast Cancer

  • NCT00124514Phase 2Completed31 enrolled2003

    Triptorelin for Ovary Protection in Childhood Onset Lupus

    Children's Hospital Medical Center, Cincinnati

    Systemic Lupus Erythematosus

  • NCT00764166Phase 3Unknown254 enrolled2003

    A Prospective Randomized Phase III Study Comparing Hormonal Therapy +/-Docetaxel

    Assistance Publique - Hôpitaux de Paris

    Adenocarcinoma of the Prostate

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT02749825Phase 4Terminated41 enrolled2002

    Comparison of Trelstar Versus Lupron or Zoladex in Advanced Prostate Cancer

    Pharmatech

    Prostate Cancer

  • NCT01160315Phase 2/3Completed118 enrolled2002

    Efficiency of Gonadotropin-releasing Hormone (GnRH) Agonist in Preventing Chemotherapy Induced Ovarian Failure

    Erasme University Hospital

    Fertility Preservation · Alkylating Agents · Lymphoma

  • NCT00004054Phase 3Completed397 enrolled2000

    Hormone Therapy Plus Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Prostate Cancer

    Radiation Therapy Oncology Group

    Prostate Cancer

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT00003734Phase 3Unknown276 enrolled1998

    Combination Hormone Therapy Followed by Radiation Therapy in Treating Patients With Prostate Cancer

    St. Luke's Hospital, Ireland

    Prostate Cancer

  • NCT00003026Phase 3Completed966 enrolled1997

    Hormone Therapy in Treating Patients With Advanced Prostate Cancer

    European Organisation for Research and Treatment of Cancer - EORTC

    Prostate Cancer

  • ISRCTN8216162940 enrolled1993

    A study on the efficacy of the combination of growth hormone (GH) and gonadotropin releasing hormone analogues (GnRHa) on adult height in children with idiopathic short stature

    Pfizer B.V. (Netherlands) (Pfizer Inc, New York)

    Small for Gestational Age (SGA), children with persistent short stature

  • NCT00438217Phase 4Unknown100 enrolled

    Analysis of Genetic and Environmental Parameters Influencing Growth Rate of Precocious Puberty Children

    University of Pisa

    Central Precocious Puberty

  • 2024-516621-31-00Authorised, Not Started154 enrolled

    FSD-NAF-2024-11

    Santiago Dexeus Font Fundacio Privada

    Infertility

  • 2024-520093-34-00Authorised, Not Started310 enrolled

    ASST-FRADIO-SPA-2020

    Azienda Socio Sanitaria Territoriale Degli Spedali Civili Di Brescia, Azienda Socio Sanitaria Territoriale Degli Spedali Civili Di Brescia

    Acinar cell prostatic carcinoma

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • 2024-510596-37-0011100 enrolled

    Transdermal testosterone pretreatment in poor responders with androgen receptor polymorphism undergoing ICSI: A Randomized Clinical Investigation.

    Instituto Bernabeu S.L.

    low ovarian reserve according to Bologna criteria and carriers of androgen receptor polymorphism

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • 2024-510596-37-01Authorised, Not Started100 enrolled

    Transdermal testosterone pretreatment in poor responders with androgen receptor polymorphism undergoing ICSI: A Randomized Clinical Investigation.

    Instituto Bernabeu S.L.

    low ovarian reserve according to Bologna criteria and carriers of androgen receptor polymorphism

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • 2025-524761-25-00Authorised, Not Started240 enrolled

    FSD-QUA-2025-27

    Santiago Dexeus Font Fundacio Privada

    infertility

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • 2022-500308-23-00Authorised, Not Started115 enrolled

    A randomised, controlled, assessor-blind, parallel groups, multicentre, multinational trial comparing the ovarian response after controlled ovarian stimulation with mixed protocols of follitropin delta (REKOVELLE) and highly purified human menopausal gonadotropin (MENOPUR) in women undergoing an assisted reproductive technology programme

    Ferring Pharmaceuticals A/S

    Infertility in women undergoing assisted reproductive technologies (ART) such as an in vitro fertilisation (IVF) or intracytoplasmic sperm injection (ICSI) cycle

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

Sources: ClinicalTrials.gov, the EU Clinical Trials Information System and ISRCTN, deduplicated so a study registered in more than one registry is counted once. A study is listed when Triptorelin is named as an intervention. A registered trial is a plan, not a result — registration says nothing about whether the peptide worked.